MSWM
NVRO

McGlone Suttner Wealth Management’s NEVRO CORP. NVRO Stock Holding History

McGlone Suttner Wealth Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-300
Closed -$6.46K – 806
2023
Q4 		$6.46K Buy
+300
New +$5.35K ﹤0.01% 554

Other funds holding NVRO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

McGlone Suttner Wealth Management's NVRO Position: Q1 2024 in Review

McGlone Suttner Wealth Management sold out of NEVRO CORP. (NVRO) in Q1 2024, closing a stake of 300 shares — an estimated $6.46K sold.

McGlone Suttner Wealth Management first reported a position in NVRO in Q4 2023 and held it in 1 quarter. The position peaked at $6.46K in Q4 2023. 153 funds tracked by Wall St. Rank hold NVRO as of Q1 2024.

  • McGlone Suttner Wealth Management reported no remaining NEVRO CORP. position as of Q1 2024 after selling out during the quarter.
  • McGlone Suttner Wealth Management sold 300 NEVRO CORP. shares in Q1 2024, an estimated $6.46K.
  • McGlone Suttner Wealth Management first reported a position in NEVRO CORP. in Q4 2023 and held it in 1 quarter.
  • McGlone Suttner Wealth Management's NEVRO CORP. position peaked at $6.46K in Q4 2023.
  • 153 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2024.

Based on McGlone Suttner Wealth Management's 13F filing for Q1 2024, filed 18 Apr 2024.